Your choice of outcome measures determines the success
of your trial and how much it will encroach on your budget.
An ideal outcome measure is valid, reliable, responsive
to clinical change and cost effective. Osteoarthritis is a
common target disease for the development of therapeutic
interventions and is used here as an example by Jacky
Reid, CEO of Newmetrica.

Download (PDF, 334KB)

Comments are closed.